Recorlev (levoketoconazole), Strongbridge Biopharma's oral investigational therapy for endogenous Cushing's syndrome, resulted in sustained improvements in cortisol and glycemic control in patients with Cushing...
Reuters videosDisaster and Disease: The Suffering of Australian TourismImagine arriving at a resort for a late check-in to find out that the place was...